Cancer Research UK’s Karen Vousden is set to join Bristol-Myers Squibb’s board of directors in January.
Vousden is currently chief scientist at Cancer Research UK, as well as serving as group leader at the Francis Crick Institute in London, will also sit the pharma firm’s Science and Technology Committee.
She has more than 30 years experience in cancer research and her previous roles have included director of the Beatson Institute for Cancer Research and leadership positions at the US National Cancer Institute.
Giovanni Caforio, BMS’ chairman and chief executive officer, said: “Karen is a world class cancer researcher and a highly accomplished leader in her field.
“Her understanding of cancer biology and immunology research will bring valuable insights to advancing our strategy and strong pipeline in oncology along with our broader pipeline of transformational medicines.”